Mn Services Vermogensbeheer B.V. lessened its position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 2.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,300 shares of the biotechnology company’s stock after selling 700 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Axon Enterprise were worth $10,909,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of AXON. Motley Fool Asset Management LLC raised its position in shares of Axon Enterprise by 238.7% in the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after buying an additional 346,838 shares during the last quarter. 1832 Asset Management L.P. acquired a new position in Axon Enterprise during the first quarter worth approximately $81,630,000. International Assets Investment Management LLC acquired a new position in Axon Enterprise during the third quarter worth approximately $871,860,000. Vanguard Group Inc. increased its position in Axon Enterprise by 2.7% during the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after purchasing an additional 212,401 shares during the last quarter. Finally, Swedbank AB acquired a new position in Axon Enterprise during the first quarter worth approximately $39,923,000. Institutional investors and hedge funds own 79.08% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently commented on the stock. Needham & Company LLC upped their price target on shares of Axon Enterprise from $400.00 to $525.00 and gave the stock a “buy” rating in a research report on Tuesday, October 22nd. Barclays upped their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Jefferies Financial Group assumed coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target for the company. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Finally, Northland Securities boosted their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research note on Thursday, August 8th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $392.85.
Axon Enterprise Price Performance
Shares of AXON stock opened at $441.09 on Wednesday. The company has a market capitalization of $33.33 billion, a PE ratio of 116.38, a price-to-earnings-growth ratio of 10.84 and a beta of 0.94. The firm has a fifty day simple moving average of $403.76 and a 200-day simple moving average of $342.09. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a twelve month low of $212.88 and a twelve month high of $455.17.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business’s quarterly revenue was up 34.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.80 earnings per share. Equities research analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.
Insider Activity
In other news, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $353.53, for a total value of $318,177.00. Following the completion of the transaction, the director now directly owns 3,653 shares in the company, valued at approximately $1,291,445.09. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Jeri Williams sold 110 shares of the company’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $400.00, for a total value of $44,000.00. Following the sale, the director now owns 1,934 shares in the company, valued at approximately $773,600. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the sale, the director now owns 3,653 shares in the company, valued at approximately $1,291,445.09. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 371,172 shares of company stock worth $137,000,162. 5.70% of the stock is currently owned by company insiders.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Palantir Cracks $50, Is There Still Time to Get on Board?
- What is the Nasdaq? Complete Overview with History
- Insider Buying Signals Upside for These 3 Stocks
- The 3 Best Blue-Chip Stocks to Buy Now
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.